The prostate-specific antigen (PSA) test is a blood test designed to measure the presence of prostate-specific antigen in the body. Its primary purpose is to screen for and monitor prostate cancer in men by assessing the levels of prostate-specific antigen in the bloodstream.
The main types of PSA tests include clinical laboratory improvement amendments (CLIA), enzyme-linked immunosorbent assay (ELISA), fluorescence immunoassay (FIA), and others. Clinical laboratory improvement amendments (CLIA) comprise a set of regulations governing laboratory testing, requiring clinical laboratories to obtain certification from the Centers for Medicare & Medicaid Services (CMS) before conducting diagnostic testing on human samples. These tests find applications in various areas, including screening and post-treatment monitoring, and are utilized by diverse end-users such as hospitals, diagnostic centers, research institutes, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The prostate-specific antigen (PSA) test market research report is one of a series of new reports from The Business Research Company that provides prostate-specific antigen (PSA) test market statistics, including prostate-specific antigen (PSA) test industry global market size, regional shares, competitors with a prostate-specific antigen (PSA) test market share, detailed prostate-specific antigen (PSA) test market segments, market trends and opportunities, and any further data you may need to thrive in the prostate-specific antigen (PSA) test industry. This prostate-specific antigen (PSA) test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The prostate specific antigen (psa) test market size has grown rapidly in recent years. It will grow from $4.15 billion in 2024 to $4.65 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increased awareness, aging population, medical advancements, clinical recommendations, pharmaceutical advancements.
The prostate specific antigen (psa) test market size is expected to see rapid growth in the next few years. It will grow to $7.27 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to advancements in test accuracy, personalized medicine approach, personalized medicine approach, global aging population. Major trends in the forecast period include shift towards biomarker combinations, technological innovations, point-of-care testing, digital health integration, focus on early detection and prevention.
The forecast of 11.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of Prostate Specific Antigen assay reagents and automated lab analyzers sourced from South Korea and Italy, thereby slowing early cancer detection and elevating clinical lab operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The projected expansion of the prostate-specific antigen (PSA) test market is fueled by the increasing incidence of prostate cancer. Prostate cancer, affecting the prostate gland in the male reproductive system, is a condition that warrants early detection and risk assessment. The PSA test serves as a prevalent screening tool for prostate cancer, measuring PSA levels in the bloodstream. Recent reports from the American Society of Clinical Oncology (ASCO) in March 2023 revealed that in the United States alone, an estimated 288,300 men were diagnosed with prostate cancer, with approximately 34,700 succumbing to the disease in 2023. Globally, it is anticipated that around 1,414,259 individuals will be diagnosed with prostate cancer in 2020. Consequently, the escalating prevalence of prostate cancer is a driving force behind the growth of the PSA test market.
The upswing in chronic diseases contributes to the burgeoning demand for PSA tests. Chronic diseases, characterized by prolonged medical conditions necessitating ongoing attention and management, include prostate cancer as one such condition. The PSA test emerges as a pivotal tool for screening, diagnosis, and monitoring the progression of prostate cancer. Predictions from the National Library of Medicine in 2022 anticipate a 99.5% rise in the number of individuals aged 50 and older with at least one chronic illness, reaching 142.66 million by 2050. Furthermore, the prevalence of multimorbidity is projected to increase by 91.16%, encompassing 14.968 million people in 2050. Hence, the upsurge in chronic diseases is poised to propel the PSA test market.
A prominent trend in the PSA test market is the integration of technological advancements. Key players in the market are actively developing advanced screening tools to maintain their competitive edge. LynxDx Inc., a US-based diagnostic company, exemplifies this trend with the launch of MyProstateScore 2.0 in February 2023. This non-invasive urine prostate cancer screening test employs 18 biomarkers, including the innovative gene fusion T2,ERG, for personalized risk assessment. MyProstateScore 2.0 not only delivers highly accurate, stratified risk assessment insights but also guides clinical decisions for patients exhibiting elevated PSA or abnormal digital rectal exam (DRE) findings.
Major companies in the PSA test market are focusing on product development and launches, such as home testing kits for PSA. Home testing kits, facilitating self-administered diagnostic procedures, offer convenience and accessibility. In September 2023, Randox, an Ireland-based health and toxicology company, unveiled an at-home testing kit for PSA. This kit enables individuals to measure PSA levels in their blood, providing indications of abnormalities within the prostate. Elevated PSA levels may signal various conditions, including an enlarged prostate, prostatitis, urinary tract infection, or the potential presence of prostate cancer.
In June 2024, AstraZeneca PLC, a biopharmaceutical company based in the UK, acquired Fusion Pharmaceuticals Inc. for an undisclosed sum. This acquisition is intended to enhance AstraZeneca PLC's advanced radioconjugate technology for more precise cancer treatments. Fusion Pharmaceuticals Inc. is a clinical-stage oncology company located in Canada that offers prostate-specific antigen (PSA) tests.
Major companies operating in the prostate specific antigen (PSA) test market include Siemens AG, F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Becton Dickinson and Company, PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin SpA, OPKO Health Inc., R&D Systems Inc., Meso Scale Diagnostics LLC, Tosoh America Inc., Fujirebio Europe N.V., Boditech Med Inc., DRG International Inc., BioVision Inc., Enzo Life Sciences Inc., RayBiotech Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Elabscience, LifeSpan BioSciences Inc., American Laboratory Products Company Ltd., Accuquik Inc.
North America was the largest region in the prostate specific antigen (PSA) test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (psa) test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the prostate specific antigen (psa) test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The prostate-specific antigen (PSA) test market includes revenues earned by entities by providing services such as prostate cancer detection, monitoring, PSA screening, prostatitis evaluation, complex PSA tests, and blood tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Prostate Specific Antigen (PSA) Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on prostate specific antigen (psa) test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for prostate specific antigen (psa) test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The prostate specific antigen (psa) test market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Clinical Laboratory Improvement Amendments (CLIA); Enzyme-Linked Immunosorbent Assay (ELISA); Fluorescence Immunoassay (FIA); Other Types
- 2) By Application: Screening; Post-Treatment Monitoring; Other Applications
- 3) By End User: Hospitals; Diagnostic Centers; Research Institutes; Other End Users
- Subsegments:
- 1) By Clinical Laboratory Improvement Amendments (CLIA): CLIA Waived Tests; Non-CLIA Tests
- 2) By Enzyme-Linked Immunosorbent Assay (ELISA): Sandwich ELISA Kits; Competitive ELISA Kits
- 3) By Fluorescence Immunoassay (FIA): Point-Of-Care FIA; Laboratory-Based FIA
- 4) By Other Types: Chemiluminescent Immunoassay (CLIA); Radioimmunoassay (RIA)
- Companies Mentioned: Siemens AG; F. Hoffmann-La Roche AG; Bayer AG; Abbott Laboratories; Becton Dickinson and Company; PerkinElmer Inc.; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; Ortho-Clinical Diagnostics Inc.; DiaSorin SpA; OPKO Health Inc.; R&D Systems Inc.; Meso Scale Diagnostics LLC; Tosoh America Inc.; Fujirebio Europe N.V.; Boditech Med Inc.; DRG International Inc.; BioVision Inc.; Enzo Life Sciences Inc.; RayBiotech Inc.; Novus Biologicals LLC; Creative Diagnostics Inc.; Elabscience; LifeSpan BioSciences Inc.; American Laboratory Products Company Ltd.; Accuquik Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Prostate Specific Antigen (PSA) Test Market Characteristics
3. Prostate Specific Antigen (PSA) Test Market Trends And Strategies
4. Prostate Specific Antigen (PSA) Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Prostate Specific Antigen (PSA) Test Growth Analysis And Strategic Analysis Framework
- 5.1. Global Prostate Specific Antigen (PSA) Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Prostate Specific Antigen (PSA) Test Market Growth Rate Analysis
- 5.4. Global Prostate Specific Antigen (PSA) Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Prostate Specific Antigen (PSA) Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Prostate Specific Antigen (PSA) Test Total Addressable Market (TAM)
6. Prostate Specific Antigen (PSA) Test Market Segmentation
- 6.1. Global Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Clinical Laboratory Improvement Amendments (CLIA)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Fluorescence Immunoassay (FIA)
- Other Types
- 6.2. Global Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Screening
- Post-Treatment Monitoring
- Other Applications
- 6.3. Global Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Diagnostic Centers
- Research Institutes
- Other End Users
- 6.4. Global Prostate Specific Antigen (PSA) Test Market, Sub-Segmentation Of Clinical Laboratory Improvement Amendments (CLIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- CLIA Waived Tests
- Non-CLIA Tests
- 6.5. Global Prostate Specific Antigen (PSA) Test Market, Sub-Segmentation Of Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sandwich ELISA Kits
- Competitive ELISA Kits
- 6.6. Global Prostate Specific Antigen (PSA) Test Market, Sub-Segmentation Of Fluorescence Immunoassay (FIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Point-Of-Care FIA
- Laboratory-Based FIA
- 6.7. Global Prostate Specific Antigen (PSA) Test Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemiluminescent Immunoassay (CLIA)
- Radioimmunoassay (RIA)
7. Prostate Specific Antigen (PSA) Test Market Regional And Country Analysis
- 7.1. Global Prostate Specific Antigen (PSA) Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Prostate Specific Antigen (PSA) Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Prostate Specific Antigen (PSA) Test Market
- 8.1. Asia-Pacific Prostate Specific Antigen (PSA) Test Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Prostate Specific Antigen (PSA) Test Market
- 9.1. China Prostate Specific Antigen (PSA) Test Market Overview
- 9.2. China Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Prostate Specific Antigen (PSA) Test Market
- 10.1. India Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Prostate Specific Antigen (PSA) Test Market
- 11.1. Japan Prostate Specific Antigen (PSA) Test Market Overview
- 11.2. Japan Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Prostate Specific Antigen (PSA) Test Market
- 12.1. Australia Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Prostate Specific Antigen (PSA) Test Market
- 13.1. Indonesia Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Prostate Specific Antigen (PSA) Test Market
- 14.1. South Korea Prostate Specific Antigen (PSA) Test Market Overview
- 14.2. South Korea Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Prostate Specific Antigen (PSA) Test Market
- 15.1. Western Europe Prostate Specific Antigen (PSA) Test Market Overview
- 15.2. Western Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Prostate Specific Antigen (PSA) Test Market
- 16.1. UK Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Prostate Specific Antigen (PSA) Test Market
- 17.1. Germany Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Prostate Specific Antigen (PSA) Test Market
- 18.1. France Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Prostate Specific Antigen (PSA) Test Market
- 19.1. Italy Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Prostate Specific Antigen (PSA) Test Market
- 20.1. Spain Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Prostate Specific Antigen (PSA) Test Market
- 21.1. Eastern Europe Prostate Specific Antigen (PSA) Test Market Overview
- 21.2. Eastern Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Prostate Specific Antigen (PSA) Test Market
- 22.1. Russia Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Prostate Specific Antigen (PSA) Test Market
- 23.1. North America Prostate Specific Antigen (PSA) Test Market Overview
- 23.2. North America Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Prostate Specific Antigen (PSA) Test Market
- 24.1. USA Prostate Specific Antigen (PSA) Test Market Overview
- 24.2. USA Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Prostate Specific Antigen (PSA) Test Market
- 25.1. Canada Prostate Specific Antigen (PSA) Test Market Overview
- 25.2. Canada Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Prostate Specific Antigen (PSA) Test Market
- 26.1. South America Prostate Specific Antigen (PSA) Test Market Overview
- 26.2. South America Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Prostate Specific Antigen (PSA) Test Market
- 27.1. Brazil Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Prostate Specific Antigen (PSA) Test Market
- 28.1. Middle East Prostate Specific Antigen (PSA) Test Market Overview
- 28.2. Middle East Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Prostate Specific Antigen (PSA) Test Market
- 29.1. Africa Prostate Specific Antigen (PSA) Test Market Overview
- 29.2. Africa Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Prostate Specific Antigen (PSA) Test Market Competitive Landscape And Company Profiles
- 30.1. Prostate Specific Antigen (PSA) Test Market Competitive Landscape
- 30.2. Prostate Specific Antigen (PSA) Test Market Company Profiles
- 30.2.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
31. Prostate Specific Antigen (PSA) Test Market Other Major And Innovative Companies
- 31.1. PerkinElmer Inc.
- 31.2. Beckman Coulter Inc.
- 31.3. Bio-Rad Laboratories Inc.
- 31.4. Ortho-Clinical Diagnostics Inc.
- 31.5. DiaSorin SpA
- 31.6. OPKO Health Inc.
- 31.7. R&D Systems Inc.
- 31.8. Meso Scale Diagnostics LLC
- 31.9. Tosoh America Inc.
- 31.10. Fujirebio Europe N.V.
- 31.11. Boditech Med Inc.
- 31.12. DRG International Inc.
- 31.13. BioVision Inc.
- 31.14. Enzo Life Sciences Inc.
- 31.15. RayBiotech Inc.
32. Global Prostate Specific Antigen (PSA) Test Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Prostate Specific Antigen (PSA) Test Market
34. Recent Developments In The Prostate Specific Antigen (PSA) Test Market
35. Prostate Specific Antigen (PSA) Test Market High Potential Countries, Segments and Strategies
- 35.1 Prostate Specific Antigen (PSA) Test Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Prostate Specific Antigen (PSA) Test Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Prostate Specific Antigen (PSA) Test Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
